8001 - 8010 of 8587 Results
Title
Year
-
OPENTitle: Rapid motor progression of Parkinson’s disease associates with clinical and genetic variantsJournal Name: Frontiers in Bioscience-LandmarkPublisher: IMR PressVol: 26Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.52586/5044Best OA location URL: https://www.imrpress.com/journal/FBL/26/12/10.52586/5044/pdfCitation Count: 9
- Analysis of factors associated with early stage Parkinson’s disease based on daily activities and sleeping behaviour disorder2021OPENTitle: Analysis of factors associated with early stage Parkinson’s disease based on daily activities and sleeping behaviour disorderJournal Name: Journal of Physics: Conference SeriesPublisher: IOP PublishingVol: 1722Issue #: 1Start Page: 012045End Page: 012045Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012045Best OA location URL: https://iopscience.iop.org/article/10.1088/1742-6596/1722/1/012045/pdfCitation Count: 1
- Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer’s Disease or Dementia with Lewy Bodies2021OPENTitle: Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer’s Disease or Dementia with Lewy BodiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 80Issue #: 4Start Page: 1603End Page: 1612Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-200323Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10109539Citation Count: 4
- Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer’s Disease and Mild Cognitive Impairment2021RESTRICTEDTitle: Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer’s Disease and Mild Cognitive ImpairmentJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 82Issue #: 2Start Page: 541End Page: 560Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-201457Citation Count: 23
- Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter Alterations2021RESTRICTEDTitle: Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter AlterationsJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 82Issue #: s1Start Page: S5End Page: S18Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-201195Citation Count: 9
- Improving Patient Outreach by Defining Telehealth Suitability in a Tertiary Huntington’s Disease Clinic2021RESTRICTEDTitle: Improving Patient Outreach by Defining Telehealth Suitability in a Tertiary Huntington’s Disease ClinicJournal Name: Journal of Huntington's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 479End Page: 484Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jhd-210498Citation Count: 4
-
OPENTitle: Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 1Start Page: 177End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202285Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202285?id=journal-of-parkinsons-disease%2Fjpd202285Citation Count: 49
- Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study2021OPENTitle: Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1079End Page: 1089Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212594Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212594?id=journal-of-parkinsons-disease%2Fjpd212594Citation Count: 49
- The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers2021OPENTitle: The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their CarersJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1309End Page: 1323Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212611Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212611?id=journal-of-parkinsons-disease%2Fjpd212611Citation Count: 15
-
RESTRICTEDTitle: Non-Motor Features of Parkinson’s Disease in WomenJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1237End Page: 1246Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202409Citation Count: 10